US2006088590A1PendingUtilityA1

Non-blooming gelatin and non-gelatin formulations

Assignee: BANNER PHARMACAPS INCPriority: Oct 22, 2004Filed: Mar 18, 2005Published: Apr 27, 2006
Est. expiryOct 22, 2024(expired)· nominal 20-yr term from priority
A61K 9/4866A61K 9/4825A61K 9/4816A61K 9/4858
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A non-blooming plasticizer composition and methods of using the composition are described herein. The composition is a mixture of sorbitol and sorbitan wherein the ratio of sorbitan and sorbitol is between about 0.40 and about 1.2 by weight, more preferably from about 0.45-0.50 to about 0.70 by weight, wherein the composition contains less than 20% of other dextrose hydrolytic degradation products. The non-blooming plasticizer compositions can be mixed, alone or in combination with other shell additives, with gelatin or non-gelatin materials to prepare soft capsules for the delivery of pharmaceutical, nutritional and personal care products, such as bath oils, shampoos and conditioners, and skin lotions.

Claims

exact text as granted — not AI-modified
1 . A non-blooming gelatin and non-gelatin plasticizer composition comprising a mixture of sorbitol and sorbitan wherein the ratio of sorbitan to sorbitol is between about 0.40 and about 1.2 by weight and wherein the composition comprises less than 20% of other dextrose hydrolytic degradation products.  
   
   
       2 . The composition of  claim 1 , wherein the ratio of sorbitan to sorbitol is 0.50 to 0.70 by weight.  
   
   
       3 . The composition of  claim 1  wherein the composition comprises other plasticizers selected from the group consisting of glycerin, propylene glycol or maltitol.  
   
   
       4 . A method of making a non-blooming soft capsule shell comprising providing in the soft capsule shell composition a plasticizer comprising a mixture of sorbitol and sorbitan wherein the ratio of sorbitan to sorbitol is between about 0.40 and about 1.2 by weight and wherein the composition comprises less than 20% of other dextrose hydrolytic degradation products.  
   
   
       5 . The method of  claim 4  further comprising encapsulating a fill material in the soft capsule shell.  
   
   
       6 . The method of  claim 4  wherein the soft capsule shell composition comprises the plasticizer and gelatin.  
   
   
       7 . The method of  claim 4 , wherein the ratio of sorbitan to sorbitol is between about 0.50 and 0.70 by weight.  
   
   
       8 . A soft gel capsule for making a pharmaceutical dosage form comprising a non-blooming plasticizer composition comprising a mixture of sorbitol and sorbitan wherein the ratio of sorbitan to sorbitol is between about 0.40 and about 1.2 by weight and wherein the composition comprises less than 20% of other dextrose hydrolytic degradation products.  
   
   
       9 . The soft gel capsule of  claim 8 , wherein the ratio of sorbitan to sorbitol is 0.50 to 0.70 by weight.  
   
   
       10 . The soft gel capsule of  claim 8  wherein the soft capsule shell further comprises other plasticizers selected from the group consisting of glycerin, propylene glycol or maltitol.  
   
   
       11 . The soft gel capsule of  claim 8  wherein the soft capsule shell comprises gelatin.  
   
   
       12 . The soft gel capsule of  claim 8  comprising at least one pharmaceutically active agent in a therapeutically effective amount encapsulated in the soft capsule shell.  
   
   
       13 . The soft gel capsule of  claim 12  wherein the agent is selected from the group consisting of analgesics, anti-inflammatory agents, antihelmintics, anti-arrhythmic agents, anti-bacterial agents, anti-viral agents, anti-hypertensive agents, anti-coagulants, anti-depressants, anti-diabetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-malarials, anti-migraine agents, anti -muscarinic agents, anti-neoplastic agents, erectile dysfunction improvement agents, immunosupressants, anti-protozoal agents, anti-thyroid agents, anxiolytic agents, sedatives, hypnotics, neuroleptics, β-blockers, cardiac inotropic agents, corticosteroids, diuretics, anti-parkinsonian agents, gastro-intestinal agents, histamine H 1  and H 2  receptor antagonists, keratolytics, lipid regulating agents, anti-anginal agents, nutritional agents, opioid analgesics, sex hormones, stimulants, muscle relaxants, anti-osteoporosis agents, anti-obesity agents, cognition enhancers, anti-urinary incontinence agents, nutritional oils, anti-benign prostate hypertrophy agents, essential fatty acids, non essential fatty acids, vitamins, minerals and mixtures thereof.

Join the waitlist — get patent alerts

Track US2006088590A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.